VBI Vaccines Inc Uncategorized Contracts & Agreements

27 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Extension Agreement, dated November 3, 2023, by and among VBI Vaccines Inc., Variation Biotechnologies Inc. and K2 HealthVentures LLC
VBI Vaccines Inc
Biotechnology
2023
Extension Agreement, dated October 27, 2023, by and among VBI Vaccines Inc., Variation Biotechnologies Inc. and K2 HealthVentures LLC
VBI Vaccines Inc
Biotechnology
2023
Letter Agreement, dated July 5, 2023, by and between VBI Vaccines Inc. and Brii Biosciences
VBI Vaccines Inc
Biotechnology
NY
2023
Eighth Amendment to the Collaborative Research Agreement, signed April 17, 2023, between National Research Council of Canada and Variation Biotechnologies Inc
VBI Vaccines Inc
Biotechnology
2023
Seventh Amendment to the Collaborative Research Agreement, signed February 28, 2023, between National Research Council of Canada and Variation Biotechnologies Inc
VBI Vaccines Inc
Biotechnology
2023
Open Market Sale AgreementSM, dated August 26, 2022, by and between VBI Vaccines, Inc. and Jefferies LLC
VBI Vaccines Inc
Biotechnology
NY
2022
Sixth Amendment to the Collaborative Research Agreement, signed April 28, 2022, between National Research Council of Canada and Variation Biotechnologies Inc
VBI Vaccines Inc
Biotechnology
2022
Fifth Amendment Five to the Collaborative Research Agreement, signed February 8, 2022, between National Research Council of Canada and Variation Biotechnologies Inc
VBI Vaccines Inc
Biotechnology
2022
Fourth Amendment to the Collaborative Research Agreement, signed November 15, 2021, between National Research Council of Canada and Variation Biotechnologies Inc
VBI Vaccines Inc
Biotechnology
2022
Third Amendment to the Collaborative Research Agreement, dated August 27, 2021, between National Research Council of Canada and Variation Biotechnologies Inc
VBI Vaccines Inc
Biotechnology
2022
Second Amendment to the Collaborative Research Agreement, dated July 8, 2021, between National Research Council of Canada and Variation Biotechnologies Inc
VBI Vaccines Inc
Biotechnology
2022
First Amendment to the Collaborative Research Agreement, dated December 21, 2020, between National Research Council of Canada and Variation Biotechnologies Inc
VBI Vaccines Inc
Biotechnology
2022
Collaborative Research Agreement, dated March 30, 2020, between National Research Council of Canada and Variation Biotechnologies Inc
VBI Vaccines Inc
Biotechnology
2022
Amendment to the Agreement signed by NRC on March 30, 2020 and Amendment One signed by NRC on December 31, 2020 and Amendment Two signed July 8, 2021 effective August 27, 2021
VBI Vaccines Inc
Biotechnology
2021
Open Market Sale Agreement, dated September 3, 2021, by and between VBI Vaccines Inc. and Jefferies LLC
VBI Vaccines Inc
Biotechnology
NY
2021
Amendment to the Agreement signed by NRC on March 30, 2020 and Amendment One signed by NRC on December 21, 2020 effective July 8, 2021
VBI Vaccines Inc
Biotechnology
2021
Amendment One to Collaborative Research Agreement between National Research Council of Canada and Variation Biotechnologies Inc. effective December 21, 2020
VBI Vaccines Inc
Biotechnology
2021
Description of Securities
VBI Vaccines Inc
Biotechnology
2021
Collaborative Research Agreement between National Research Council of Canada and Variation Biotechnologies Inc effective March 30, 2020
VBI Vaccines Inc
Biotechnology
2020
Description of Securities
VBI Vaccines Inc
Biotechnology
2020
WAIVERAGREEMENT
VBI Vaccines Inc
Biotechnology
NY
2017
WAIVERAGREEMENT
VBI Vaccines Inc
Biotechnology
NY
2017
INTELLECTUALPROPERTY AND CONFIDENTIAL INFORMATION AGREEMENT
VBI Vaccines Inc
Biotechnology
2017
CONSULTINGAGREEMENT
VBI Vaccines Inc
Biotechnology
2017
VBIVACCINES INC. INCENTIVESTOCK OPTION AGREEMENT UNDER THEINCENTIVE PLAN
VBI Vaccines Inc
Biotechnology
2017
VBIVaccines INC. IncentivePLAN EffectiveMay 6, 2016 Asamended June 23, 2016
VBI Vaccines Inc
Biotechnology
2017
IOGEN CORPORATION, (hereinafter called the Sub-sublandlord), - and - VARIATION BIOTECHNOLOGIES INC., (hereinafter called the Sub-subtenant).
VBI Vaccines Inc
Biotechnology
2016